The prevalence of hyperuricemia and sarcopenia was 23.57% and 15.34%, respectively. IBM SPSS 25.0 and GraphPad prism 8.0 software were used for data analysis and graphing. ASCVD risk was calculated using the Framingham Heart Study, and ASCVD risk ≥ 20% was considered high risk ASCVD. The Asian Working Group on Sarcopenia diagnostic criteria were used to classify patients with sarcopenia. Skeletal muscle mass was measured using bioelectrical impedance methods. This study collected information from patients ( N = 2647) who underwent health check-ups at the Health Care Building of Wuhan Union Hospital between January 2019 and December 2020. Hyperuricemia and sarcopenia are both strongly linked to an increased risk of atherosclerotic cardiovascular disease (ASCVD), and this study was designed to look into the interactive effects of hyperuricemia on ASCVD risk.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |